Enveric Biosciences signs licensing agreement with Diverse Biotech

By PBR Staff Writer

Enveric Biosciences has announced that it has signed an exclusive, perpetual licensing agreement with Diverse Biotech to develop new molecules for the treatment of cancer and other debilitating diseases.